Share of Gland Pharma opened at Rs 1,701 against the issue price of Rs 1,500 on BSE

The Rs 6,480-crore IPO (initial public offering) of Chinese-backed drug firm Gland Pharma that closed on November 11, was merely subscribed 2.06 times

India Stock Market Highlights Today: All Sensex stocks were trading in green led by ICICI Bank, Infosys, HCL Technologies, Axis Bank, HDFC Bank and Hindustan Unilever

Share market this week: Investors will react to US presidential election results, corporate earning numbers, COVID-19 cases, macro data, foreign fund flow, rupee and oil price movement

Ahead of IPO, Gland Pharma on Satuday raised Rs 1,944 crore from anchor investors at the price of Rs 1,500 per equity share

India Stock Market Highlights Today: SBI, followed by HCL Tech, Tech Mahindra, Asian Paints, Infosys, Tata Steel, TCS and Reliance Industries were among the top gainers in the Sensex pack. On the other hand, ONGC and Titan were the laggards.

The pharma company will hold a press conference today to give additional details on the IPO, which will make it the biggest IPO from the Indian pharma sector

India Stock Market Highlights Today: Infosys, followed by Sun Pharma, Tech Mahindra, HCL Tech and TCS were among the top gainers on Sensex today. On the other hand, ICICI Bank, Power Grid, Axis Bank, HDFC, and ITC were among the laggards

Gland Pharma IPO: The IPO comprises of fresh issue of shares worth up to Rs 1,250 crore and an offer for sale (OFS) of a little over 3.4 crore shares

India Stock Market Highlights Today: Global equities were mostly negative today as surging coronavirus cases and lack of clarity on the US stimulus package kept sentiments bearish

Stock Market LIVE Updates on July 13: RIL, Infosys, Tech Mahindra, Tata Steel, IndusInd Bank, HUL and Maruti were among the other gainers on Sensex pack today. On the other hand, Bharti Airtel and HDFC were among the top laggards

Apart from the fresh issue, there is an Offer for Sale (OFS) of a little over 3.4 crore shares as part of the initial public offering (IPO)

India clamps down on Chinese imports citing the one-sided nature of the engagement. But the process of weaning away industry from cheaper imports will not be easy.

Health care is clearly emerging as a blue-eyed sector for investors, partly because of some big-ticket exits recently.

Data released by private equity research firm VCCEdge shows November 2013 clocked PE investments worth $428 million across 38 deals. Health-care accounted for 47 pc of the total private equity investment during the month, followed by the financial sector and IT with $82 mn each.